Cited by 202Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesHIV, Drug Use, Sexual Risk

Methamphetamine use in the United States: Epidemiological update and implications for prevention, treatment, and harm reduction

Open access
Jones, Christopher M., Houry, Debra, Han, Beth, Baldwin, Grant, Vivolo‐Kantor, Alana, Compton, Wilson M.·2022·Annals of the New York Academy of Sciences

Abstract

Recent attention has focused on the growing role of psychostimulants, such as methamphetamine in overdose deaths. Methamphetamine is an addictive and potent stimulant, and its use is associated with a range of physical and mental health harms, overdose, and mortality. Adding to the complexity of this resurgent methamphetamine threat is the reality that the increases in methamphetamine availability and harms are occurring in the midst of and intertwined with the ongoing opioid overdose crisis. Opioid involvement in psychostimulant‐involved overdose deaths increased from 34.5% of overdose deaths in 2010 to 53.5% in 2019—an increase of more than 50%. This latest evolution of the nation's overdose epidemic poses novel challenges for prevention, treatment, and harm reduction. This narrative review synthesizes what is known about changing patterns of methamphetamine use with and without opioids in the United States, other characteristics associated with methamphetamine use, the contributions of the changing illicit drug supply to use patterns and overdose risk, motivations for couse of methamphetamine and opioids, and awareness of exposure to opioids via the illicit methamphetamine supply. Finally, the review summarizes illustrative community and health system strategies and research opportunities to advance prevention, treatment, and harm reduction policies, programs, and practices.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nyas.14688

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. [17]Han B, Cotto J, Etz K, 2021. Methamphetamine overdose deaths in the U.S. by sex and race and ethnicity. JAMA Psychiatry 7895: 564– 567. PMC8100861 33471025
  2. [23]Canadian Centre on Substance Use and Addiction. 2019. Canadian Community Epidemiology Network on Drug Use Bulletin: changes in stimulant use and related harms: focus on methamphetamine and cocaine. Accessed April 16, 2021. https://www.ccsa.ca/sites/default/files/2019-05/CCSA-CCENDU-Stimulant-Use-Related-Harms-Bulletin-2019-en.pdf.
  3. [31]Center for Behavioral Health Statistics and Quality. 2020. Results from the 2019 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration. 39437027
  4. [75]Bureau of Justice Assistance. Overdose fatality review data system guidance version 1.0. 2020. Accessed May 7, 2021. https://www.cossapresources.org/Content/Documents/Articles/OFR_Data_System_Guidance_Oct_2020.pdf.
  5. [108]McMahan WM, Kingston S, Newman A, Stekler JD, 2020. Interest in reducing methamphetamine and opioid use among syringe services program participants in Washington State. Drug Alcohol Depend. 216: 108243. 32911134 PMC9632690
  6. [125]Jones CM, Compton WM & Mustaquim D. 2020. Patterns and characteristics of methamphetamine use among adults – United States, 2015–2018. Morb. Mortal. Wkly. Rep 69: 317– 323. PMC7725509 32214077
  7. [126]Jones CM, Olsen EO, O’Donnell J, 2020. Resurgent methamphetamine use at treatment admission in the United States, 2008–2017. Am. J. Public Health 110: 509– 516. 32078347 PMC7067087

Cited by

Sorted by citations

Authors
Jones, C. M., Houry, D., Han, B., Baldwin, G., Vivolo‐Kantor, A., & Compton, W. M.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • National Institutes of Health (US)
  • Division of Overdose Prevention, National Center for Injury Prevention and Control Centers for Disease Control and Prevention Atlanta Georgia
Corresponding author
Jones, Christopher M.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2021-09-24
Volume
1508
Issue
1
Pages
3-22
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W3199254314
Cited by
202
References
100
Citations by year
2026: 45 · 2025: 48 · 2024: 57 · 2023: 33 · 2022: 18
FWCI
4.81
Type
journal article
Language
en
Open access
Locations
  • Annals of the New York Academy of Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (CC999999)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Keywords
methamphetamine, psychostimulants, opioid overdose, polydrug use, illicit drug supply, drug use patterns, harm reduction, substance use prevention, addiction treatment, causes of drug use, United States
MeSH terms
Opioid Epidemic, Humans, Methamphetamine, Illicit Drugs, United States, Harm Reduction, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review